Cargando…

ExoU-induced redox imbalance and oxidative stress in airway epithelial cells during Pseudomonas aeruginosa pneumosepsis

ExoU is a potent proinflammatory toxin produced by Pseudomonas aeruginosa, a major agent of severe lung infection and sepsis. Because inflammation is usually associated with oxidative stress, we investigated the effect of ExoU on free radical production and antioxidant defense mechanisms during the...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Cunha, Luiz Gonzaga, Ferreira, Miriam Francisca, de Moraes, João Alfredo, Reis, Patricia Alves, Castro-Faria-Neto, Hugo Caire, Barja-Fidalgo, Christina, Plotkowski, Maria-Cristina, Saliba, Alessandra Mattos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100071/ https://www.ncbi.nlm.nih.gov/pubmed/25904542 http://dx.doi.org/10.1007/s00430-015-0418-x

Ejemplares similares

Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis
por: Machado, Gloria-Beatriz, et al.
Publicado: (2011)

ExoU Activates NF-κB and Increases IL-8/KC Secretion during Pseudomonas aeruginosa Infection
por: de Lima, Carolina Diettrich Mallet, et al.
Publicado: (2012)

Pseudomonas aeruginosa ExoU augments neutrophil transepithelial migration
por: Pazos, Michael A., et al.
Publicado: (2017)

The Population Structure of Pseudomonas aeruginosa Is Characterized by Genetic Isolation of exoU+ and exoS+ Lineages
por: Ozer, Egon A, et al.
Publicado: (2019)

Association between possession of ExoU and antibiotic resistance in Pseudomonas aeruginosa
por: Subedi, Dinesh, et al.
Publicado: (2018)

Type III Secretion of ExoU Is Critical during Early Pseudomonas aeruginosa Pneumonia
por: Howell, Heather A., et al.
Publicado: (2013)

Pseudomonas aeruginosa Type III Secretory Toxin ExoU and Its Predicted Homologs
por: Sawa, Teiji, et al.
Publicado: (2016)

Pseudomonas aeruginosa Toxin ExoU as a Therapeutic Target in the Treatment of Bacterial Infections
por: Foulkes, Daniel M., et al.
Publicado: (2019)

Pseudomonas aeruginosa ExoU-associated virulence in HCT recipients and patients with hematologic malignancies
por: Fontana, Lauren, et al.
Publicado: (2023)

Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran
por: Azimi, Somayeh, et al.
Publicado: (2016)

Emergence of ST463 exoU-Positive, Imipenem-Nonsusceptible Pseudomonas aeruginosa Isolates in China
por: Zhu, Ying, et al.
Publicado: (2023)

Structural Basis of Cytotoxicity Mediated by the Type III Secretion Toxin ExoU from Pseudomonas aeruginosa
por: Gendrin, Claire, et al.
Publicado: (2012)

Host phospholipid peroxidation fuels ExoU-dependent cell necrosis and supports Pseudomonas aeruginosa-driven pathology
por: Bagayoko, Salimata, et al.
Publicado: (2021)

High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant “high-risk clones” of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals
por: Horna, Gertrudis, et al.
Publicado: (2019)

Evaluation of inflammatory parameters and cognitive impairment in a murine model of Pseudomonas aeruginosa pneumosepsis
por: Magno, Flora, et al.
Publicado: (2013)

Phenotypic and Genomic Comparison of the Two Most Common ExoU-Positive Pseudomonas aeruginosa Clones, PA14 and ST235
por: Fischer, Sebastian, et al.
Publicado: (2020)

ExoU Induces Lung Endothelial Cell Damage and Activates Pro-Inflammatory Caspase-1 during Pseudomonas aeruginosa Infection
por: Hardy, Kierra S., et al.
Publicado: (2022)

Characterization of the ExoU activation mechanism using EPR and integrative modeling
por: Tessmer, Maxx H., et al.
Publicado: (2020)

Perspectives on the Pseudomonas aeruginosa Type III Secretion System Effector ExoU and Its Subversion of the Host Innate Immune Response to Infection
por: Hardy, Kierra S., et al.
Publicado: (2021)

Utilizing in silico and in vitro methods to identify possible binding sites of a novel ligand against Pseudomonas aeruginosa phospholipase toxin ExoU
por: Chamberlain, Krista, et al.
Publicado: (2021)

The bacterial toxin ExoU requires a host trafficking chaperone for transportation and to induce necrosis
por: Deruelle, Vincent, et al.
Publicado: (2021)

The Pseudomonas aeruginosa Type III Secretion System Exoenzyme Effector ExoU Induces Mitochondrial Damage in a Murine Bone Marrow-Derived Macrophage Infection Model
por: Hardy, Kierra S., et al.
Publicado: (2022)

Structure of the Type III Secretion Effector Protein ExoU in Complex with Its Chaperone SpcU
por: Halavaty, Andrei S., et al.
Publicado: (2012)

The Role of ExoS in Dissemination of Pseudomonas aeruginosa during Pneumonia
por: Rangel, Stephanie M., et al.
Publicado: (2015)

Structure and Dynamics of Type III Secretion Effector Protein ExoU As determined by SDSL-EPR Spectroscopy in Conjunction with De Novo Protein Folding
por: Fischer, Axel W., et al.
Publicado: (2017)

Correction: The Role of ExoS in Dissemination of Pseudomonas aeruginosa during Pneumonia
por: Rangel, Stephanie M., et al.
Publicado: (2015)

Intoxication of Host Cells by the T3SS Phospholipase ExoU: PI(4,5)P(2)-Associated, Cytoskeletal Collapse and Late Phase Membrane Blebbing
por: Sato, Hiromi, et al.
Publicado: (2014)

Emergence of Small Colony Variants Is an Adaptive Strategy Used by Pseudomonas aeruginosa to Mitigate the Effects of Redox Imbalance
por: Besse, Alison, et al.
Publicado: (2023)

Early bacterial spreading and inflammatory profile in a pneumosepsis model
por: de Carvalho Gonçalves, M, et al.
Publicado: (2014)

Pneumosepsis survival in the setting of obesity leads to persistent steatohepatitis and metabolic dysfunction
por: Kumar, Avnee J., et al.
Publicado: (2023)

The Role of Pseudomonas aeruginosa ExoY in an Acute Mouse Lung Infection Model
por: Kloth, Christina, et al.
Publicado: (2018)

Modulation of the immune response by the Pseudomonas aeruginosa type-III secretion system
por: Jouault, Albane, et al.
Publicado: (2022)

Actin activates Pseudomonas aeruginosa ExoY nucleotidyl cyclase toxin and ExoY-like effector domains from MARTX toxins
por: Belyy, Alexander, et al.
Publicado: (2016)

Role of Host and Bacterial Lipids in Pseudomonas aeruginosa Respiratory Infections
por: Constantino-Teles, Pamella, et al.
Publicado: (2022)

Alterations in the Gut Microbiome and Cecal Metabolome During Klebsiella pneumoniae-Induced Pneumosepsis
por: Wu, Ting, et al.
Publicado: (2020)

Redox Imbalance and Stroke
por: Ye, Ruidong, et al.
Publicado: (2016)

Characterization of exo-s, exo-u, and alg virulence factors and antimicrobial resistance in Pseudomonas aeruginosa isolated from migratory Egyptian vultures from India
por: Sharma, Pradeep, et al.
Publicado: (2014)

Physical recovery of COVID‐19 pneumosepsis intensive care survivors compared with non‐COVID pneumosepsis intensive care survivors during post–intensive care hospitalization: The RECOVID retrospective cohort study
por: Moonen, Hanneke Pierre Franciscus Xaverius, et al.
Publicado: (2021)

The effector protein ExoY secreted by Pseudomonas aeruginosa is a nucleotidyl cyclase with preference for GTP
por: Voigt, Ulrike, et al.
Publicado: (2011)

The ADP-Ribosyltransferase Domain of the Effector Protein ExoS Inhibits Phagocytosis of Pseudomonas aeruginosa during Pneumonia
por: Rangel, Stephanie M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qof7hi5n8sfgespdt7l79hi3h8